Iron Uptake from Ferric Maltol in Patients with Iron Deficiency with or without Anemia: Post Hoc analysis of a Multicenter, Open-Label, Randomized, Phase 1 Clinical Study

被引：0
|
作者：
Howaldt, Stefanie [1 ]
Cody, Michael [2 ]
Mitchell, Jacqueline A. [3 ]
机构：
[1] HaFCED e K, Hamburg, Germany
[2] Shield Therapeut, Dallas, TX USA
[3] Shield Therapeut, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185768
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency
    Bokemeyer, Bernd
    Krummenerl, Annette
    Maaser, Christian
    Howaldt, Stefanie
    Mross, Michael
    Mallard, Nick
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (02) : 229 - 238
  • [2] Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency
    Bernd Bokemeyer
    Annette Krummenerl
    Christian Maaser
    Stefanie Howaldt
    Michael Mroß
    Nick Mallard
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 229 - 238
  • [3] Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension
    Pergola, Pablo E.
    Kopyt, Nelson P.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (06) : 846 - +
  • [4] Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease -: A randomized, controlled, open-label, multicenter study
    Schröder, O
    Mickisch, O
    Seidler, U
    de Weerth, A
    Dignass, AU
    Herfarth, H
    Reinshagen, M
    Schreiber, S
    Junge, U
    Schrott, M
    Stein, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2503 - 2509
  • [5] Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study
    Lee, Sanghoon
    Ryu, Ki-Jin
    Lee, Eun Sil
    Lee, Keun Ho
    Lee, Jeong Jae
    Kim, Tak
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 45 (04) : 858 - 864
  • [6] A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
    Hetzel, David
    Strauss, William
    Bernard, Kristine
    Li, Zhu
    Urboniene, Audrone
    Allen, Lee F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : 646 - 650
  • [7] Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
    Kawabata, Hiroshi
    Tamura, Takeshi
    Tamai, Soichiro
    Fujibayashi, Akiko
    Sugimura, Motoi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (05) : 647 - 658
  • [8] Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
    Hiroshi Kawabata
    Takeshi Tamura
    Soichiro Tamai
    Akiko Fujibayashi
    Motoi Sugimura
    International Journal of Hematology, 2022, 116 : 647 - 658
  • [9] Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study
    Kawabata, Hiroshi
    Tamura, Takeshi
    Tamai, Soichiro
    Takahashi, Tomoki
    Kato, Jun
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (06) : 846 - 855
  • [10] Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study
    Hiroshi Kawabata
    Takeshi Tamura
    Soichiro Tamai
    Tomoki Takahashi
    Jun Kato
    International Journal of Hematology, 2022, 116 : 846 - 855
12345